Combined use of lung ultrasound, B-type natriuretic peptide, and echocardiography for outcome prediction in patients with acute HFrEF and HFpEF

Clinical Research in Cardiology

Volumn 107, Issue 7, 2018, Pages 586-596

  Palazzuoli, Alberto ^a   Ruocco, Gaetano ^a   Beltrami, Matteo ^a   Nuti, Ranuccio ^a   Cleland, John G ^b,c  

^a UNIVERSITY OF SIENA   (Italy)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Acute HF; HFpEF; HFrEF; LUS; Risk stratification

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER;

AGED; ARTICLE; BREATHING RATE; DECELERATION; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL READMISSION; HUMAN; LUNG ARTERY PRESSURE; LUNG CONGESTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; AREA UNDER THE CURVE; BLOOD; BREATHING MECHANICS; DIAGNOSTIC IMAGING; HEART FAILURE; HEART STROKE VOLUME; KAPLAN MEIER METHOD; LUNG; LUNG EDEMA; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PULSED DOPPLER ECHOCARDIOGRAPHY; SEVERITY OF ILLNESS INDEX; TIME FACTOR;

AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOMARKERS; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG; MALE; NATRIURETIC PEPTIDE, BRAIN; PATIENT READMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EDEMA; RESPIRATORY MECHANICS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85045210853     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-018-1221-7     Document Type: Article

References (50)

1. Gheorghiade M, Zannad F, Sopko G, International Working Group on Acute Heart Failure Syndromes et al (2005) Acute heart failure syndromes: current state and framework for future research. Circulation 112:3958–3968
2. Gheorghiade M, Gattis WA, O’Connor CM; Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators et al (2004) Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA 291:1963–1971
3. Drazner MH, Rame JE, Stevenson LW, Dries DL (2001) Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 345:574–581
4. Lucas C, Johnson W, Hamilton MA et al (2000) Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am Heart J 140:840–847
5. Lala A, McNulty SE, Mentz RJ et al (2015) Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ Heart Fail 8:741–748
6. Damy T, Kallvikbacka-Bennett A, Zhang J et al (2011) Does the physical examination still have a role in patient with suspected heart failure? Eur J Heart Fail 13:1340–1348
7. Rohde LE, Beck-da-Silva L, Goldraich L et al (2004) Reliability and prognostic value of traditional signs and symptoms in outpatients with congestive heart failure. Can J Cardiol 20:697–702
8. Chakko S, Woska D, Martinez H et al (1991) Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med 90:353–359
9. Ponikowski P, Voors AA, Anker SD; Authors/Task Force Members; Document Reviewers et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18:891–975
10. Palazzuoli A, Beltrami M, Ruocco G, Franci B, Campagna MS, Nuti R (2016) Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization. Eur J Intern Med 30:43–48
11. Ricci F, Aquilani R, Radico F et al (2015) Role and importance of ultrasound lung comets in acute cardiac care. Eur Heart J Acute Cardiovasc Care 4:103–112
12. Gargani L, Frassi F, Soldati G, Tesorio P, Gheorghiade M, Picano E (2008) Ultrasound lung comets for the differential diagnosis of acute cardiogenic dyspnoea: a comparison with natriuretic peptides. Eur J Heart Fail 10:70–77
13. Gheorghiade M, Follath F, Ponikowski P; European Society of Cardiology; European Society of Intensive Care Medicine et al (2010) Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail 12:423–433
14. Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–270
15. Nagueh SF, Smiseth OA, Appleton CP et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360
16. Lancellotti P, Galderisi M, Edvardsen T et al (2017) Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study. Eur Heart J Cardiovasc Imaging 18:961–968
17. Andersen OS, Smiseth OA, Dokainish H et al (2017) Estimating left ventricular filling pressure by echocardiography. J Am Coll Cardiol 69:1937–1948
18. Volpicelli G, Elbarbary M, Blaivas M; International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS) et al (2012) International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med 38:577–591
19. Jambrik Z, Monti S, Coppola V et al (2004) Usefulness of ultrasound lung comets as a nonradiologic sign of extravascular lung water. Am J Cardiol 93:1265–1270
20. Gargani L, Pang PS, Frassi F et al (2015) Persistent pulmonary congestion before discharge predicts rehospitalization in heart failure: a lung ultrasound study. Cardiovasc Ultrasound 13:40
21. Coiro S, Rossignol P, Ambrosio G et al (2015) Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure. Eur J Heart Fail 17:1172–1181
22. Platz E, Lewis EF, Uno H et al (2016) Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J 37:1244–1251
23. Miglioranza MH, Gargani L, Sant’Anna RT et al (2013) Lung ultrasound for the evaluation of pulmonary congestion in outpatients: a comparison with clinical assessment, natriuretic peptides, and echocardiography. JACC Cardiovasc Imaging 6:1141–1151
24. Cogliati C, Casazza G, Ceriani E et al (2016) Lung ultrasound and short-term prognosis in heart failure patients. Int J Cardiol 218:104–108
25. Spevack R, Al Shukairi M, Jayaraman D, Dankoff J, Rudski L, Lipes J (2017) Serial lung and IVC ultrasound in the assessment of congestive heart failure. Crit Ultrasound J 9:7
26. Gaggin HK, Truong QA, Rehman SU et al (2013) Characterization and prediction of natriuretic peptide “nonresponse” during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail 19:135–142
27. Kubánek M, Goode KM, Lánská V, Clark AL, Cleland JG (2009) The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 11:367–377
28. Cleland JG, Teerlink JR, Davison BA; VERITAS Investigators et al (2017) Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail 19:739–747
29. Anderson KL, Jenq KY, Fields JM, Panebianco NL, Dean AJ (2013) Diagnosing heart failure among acutely dyspneic patients with cardiac, inferior vena cava, and lung ultrasonography. Am J Emerg Med 31:1208–1214
30. Mebazaa A, Yilmaz MB, Levy P et al (2015) Recommendations on pre-hospital and early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J Heart Fail 17:544–558
31. Pivetta E, Goffi A, Lupia E et al (2015) SIMEU Group for lung ultrasound in the emergency department in piedmont. Lung ultrasound-implemented diagnosis of acute decompensated heart failure in the ED. ASIMEU Multicenter Study. Chest 148:202–210
32. Farmakis D, Simitsis P, Bistola V et al (2017) Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome. Clin Res Cardiol 106:359–368
33. Cotter G, Moshkovitz Y, Kaluski E et al (2003) The role of cardiac power and systemic vascular resistance in the pathophysiology and diagnosis of patients with acute congestive heart failure. Eur J Heart Fail 5:443–551
34. Nohria A, Tsang SW, Fang JC et al (2003) Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol 41:1797–1804
35. Hasselblad V, Stough WG, Shah MR et al (2007) Relation between dose of loop diuretics and outcomes in heart failure population: results of the ESCAPE trial. Eur J Heart Fail 9:1064–1069
36. Cook TD, Greene SJ, Kalogeropoulos AP et al (2016) Temporal changes in postdischarge mortality risk after hospitalization for heart failure (from the EVEREST Trial). Am J Cardiol 117:611–616
37. Filippatos G, Farmakis D, Metra M et al (2017) Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial. Clin Res Cardiol 106:444–456
38. Shoaib A, Waleed M, Khan S et al (2014) Breathlessness at rest is not the dominant presentation of patients admitted with heart failure. Eur J Heart Fail 16:1283–1291
39. Packer M, O’Connor C, McMurray JJV; TRUE-AHF Investigators et al (2017) Effect of ularitide on cardiovascular mortality in acute heart failure. N Engl J Med;376:1956–1964
40. Gimpelewicz C, Metra M, Cleland JGF, Szecsödy P, Chang Wun CC, Boer-Martins L, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang P, Ponikowski P, Severin T, Voors AA, Teerlink JR (2017) Effects of serelaxin on the outcome of patients with or without substantial peripheral edema: a subgroup analysis from the RELAX-AHF trial. Am Heart J. 190:13–122. 10.1016/j.ahj.2017.05.012
41. Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade M (2015) The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 12:220–229
42. Mentz RJ, Kjeldsen K, Rossi GP et al (2014) Decongestion in acute heart failure. Eur J Heart Fail 16:471–482
43. Collins SP, Lindsell CJ, Storrow AB, Abraham WT; ADHERE Scientific Advisory Committee, Investigators and Study Group (2006) Prevalence of negative chest radiography results in the emergency department patient with decompensated heart failure. Ann Emerg Med 47:13–18
44. Hummel SL, Ghalib HH, Ratz D, Koelling TM (2013) Risk stratification for death and all-cause hospitalization in heart failure clinic outpatients. Am Heart J 166:895–903.e1
45. O’Connor CM, Abraham WT, Albert NM et al (2008) Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J 156:662–673
46. Cleland JG, Chiswell K, Teerlink JR et al (2014) Predictors of postdischarge outcomes from information acquired shortly after admission for acute heart failure: a report from the Placebo-Controlled Randomized Study of the Selective A1 Adenosine Receptor Antagonist Rolofylline for Patients Hospitalized With Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function (PROTECT) Study. Circ Heart Fail 7:76–87
47. Cleland JG, Carubelli V, Castiello T, Yassin A, Pellicori P, Antony R (2012) Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis. Heart Fail Rev 17:133–149
48. Schroten NF, Damman K, Valente MA et al (2016) Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction. Clin Res Cardiol 105:10–16
49. Jobs A, Brünjes K, Katalinic A et al (2017) Inferior vena cava diameter in acute decompensated heart failure as predictor of all-cause mortality. Heart Vessels 32:856–864
50. Pang PS (2017) B-lines Lung Ultrasound Guided ED Management of Acute Heart Failure Pilot Trial (BLUSHED-AHF). http://www.clinicaltrial.gov (NCT03136198)